Sfoglia per Rivista
Role for circulating endothelial cells (CECS) in endothelial injury systemic lupus erythematosus (SLE)
2005 A. Cortelezzi, M. Cortiana, N. Del Papa, I. Silvestris, G. Moroni, W. Maglione, D.P. Comina, G. Banfi
The role of 18F and 99MTC MIBI scintigraphy in predicting the clinical course of patients with multiple myeloma
2005 R. Calori, M. Castellani, L. Baldini, F. Grifoni, M. Carletto, G. Lambertenghi Deliliers
Role of CD79b and CD43 in the diagnosis of chronic B-cell lymphoproliferative syndromes
1999 L. Cro, A. Guffanti, N. Zucal, L. Nobili, C. Vener, A.T. Maiolo, L. Baldini
The role of complement in the therapeutic activity of rituximab in a murine B lymphoma model homing in lymph nodes
2006 J. Golay, E. Cittera, N. Di Gaetano, M. Manganini, M. Mosca, M. Nebuloni, N. Van Rooijen, L. Vago, M. Introna
Role of dasatinib in PH '-positive acute lymphoblastic leukemia (ALL) after imatinib-based therapy failure : a case report
2007 A. Cortelezzi, M.C. Pasquini, F. Radaelli, G. Reda, F. Ripamonti, A. Gardellini, D. Intini, O. Spinelli, G. Lambertenghi Deliliers
Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia
2000 R. Bassan, A.Z. Rohatiner, T. Lerede, E. Di Bona, A. Rambaldi, E. Pogliani, G. Rossi, P. Fabris, S. Morandi, P. Casula, M. Carter, G. Lambertenghi-Deliliers, T.A. Lister, T. Barbui
The role of notch pathway in multiple myeloma progression toward IL-6 independence
2014 S. Galletti, S. Ravaioli, M. Colombo, S. Garavelli, K. Todoerti, E. Lazzari, N. Platonova, M. Manzoni, L. Nobili, D. Ronchetti, A. Neri, R. Chiaramonte
Role of positron emission tomography in indolent non Hodgkin lymphomas
2011 F. Rossi, A. Ferrario, B. Olivero, M. Goldaniga, D. Vincenti, N. Orofino, M. Castellani, P. Gerundini, L. Baldini
Role of recombinant human granulocyte-macrophage colony stimulating factor for large scale collection of peripheral blood stem cells for autologous transplantation
1990 F. Ravagnani, M. Bregni, S. Siena, G. Sciorelli, A. M. Gianni, G. Pellegris
Role of the factor VIII-binding capacity of endogenous von Willebrand factor on the development of factor VIII inhibitors in patients with severe hemophilia A
2019 Y. Repessé, C. Costa, R. Palla, E. Farrokhi Moshai, A. Borel-Derlon, R. D'Oiron, C. Rothschild, A. El-Beshlawy, M. Elalfy, V. Ramanan, P. Eshghi, J. Oldenburg, A. Pavlova, F.R. Rosendaal, F. Peyvandi, S.V. Kaveri, S. Lacroix-Desmazes
Rosuvastatin exerts renoprotective effects in stroke-prone rats modulating the plasminogen/plasmin and metalloprotease systems
2006 A. Gianella, E. Nobili, P. Gelosa, M. Canavesi, S. Bellosta, M. Abbate, C. Zoja, E. Tremoli, L. Sironi, L. Mussoni
Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial
2016 S. Verstovsek, A.M. Vannucchi, M. Griesshammer, T. Masszi, S. Durrant, F. Passamonti, C.N. Harrison, F. Pane, P. Zachee, K. Kirito, C. Besses, M. Hino, B. Moiraghi, C.B. Miller, M. Cazzola, V. Rosti, I. Blau, R. Mesa, M.M. Jones, H. Zhen, J. Li, N. Francillard, D. Habr, J.J. Kiladjian
Safety and efficacy of low-dose subcuteneous campath-1H therapy in patients with refractory chronic lymphocytic leukaemia
2005 A. Cortelezzi, M.C. Pasquini, N.N. Fantini, V.R. Zilioli, M. Colombi, B. Sarina, G. Lambertenghi Deliliers
The safety profile of deferasirox remains consistent as non-transfusion-dependent thalassemia patients approach the target liver iron concentration of <3 mg FE/G DW for interrupting chelation
2013 A. Taher, J. Porter, V. Viprakasit, A. Kattamis, S. Chuncharunee, P. Sutcharitchan, N. Siritanaratkul, R. Galanello, Z. Karakas, D. Habr, Z. Zhu, M. Cappellini
SDF1-3'A gene polymorphism : risk factor for thrombotic events in Philadelphia-negative chronic myeloproliferative disorders
2005 C. Vanelli, M.L. Biondi, O. Turri, A. La Torre, A. Gardellini, M. Pugliano, L. Battaglioli, M. Erario, G. Gerli
SDF1-3A polymorphism in myelofibrosis with myeloid metaplasia : genotype-phenotype correlation
2006 M. Marchetti, M.L. Biondi, M. Massa, R. Campanelli, G. Bergamaschi, E. Bonetti, V. Rosti, A. Pecci, G. Gerli, G. Barosi
Second malignancies in essential thrombocytosis : a retrospective analysis of 331 patients from a single institution
2005 F. Radaelli, F.G. Rossi, F. Onida, M.C. Pasquini, P. Usardi, R. Calori, A. Zanella
Second malignancies in essential thrombocytosis: a retrospective analysis of 331 patients from a single institution (Abs. P351)
2005 F. Radaelli, S. Bramanti, R. Calori, F. Onida, M. Colombi, P. Usardi, P. Faccini, A. Zanella
SECOND PRIMARY MALIGNANCY IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB
2019 N. Polverelli, E. Elli, E. Abruzzese, G.A. Palumbo, G. Benevolo, M. Breccia, M. Tiribelli, M. Bonifacio, A. Tieghi, B. Martino, N. Sgherza, M. D’Adda, M. Bergamaschi, M. Crugnola, F. Cavazzini, C. Bosi, G. Binotto, A. Isidori, D. Bartoletti, G. Auteri, R. Latagliata, L. Gandolfi, L. Scaffidi, D. Cattaneo, K. Codeluppi, M. Trawinska, D. Griguolo, A. Cuneo, M. Krampera, G. Semenzato, F. Di Raimondo, R.M. Lemoli, M. Cavo, N. Vianelli, D. Russo, A. Iurlo, F. Palandri
Secondary malignancies in chronic lymphocytic leukemia: a single centre retrospective analysis
2016 G. Reda, B. Fattizzo, R. Cassin, N. Orofino, E. Flospergher, D. Consonni, W. Barcellini, A. Cortelezzi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile